Movie S2.

Dravet syndrome mice during ICV infusion of Hm1a. The same four animals as in Movie S1 shown >24 h after continuous ICV infusion of Hm1a (0.5 μM at 0.2 μl/min). Note that seizures have stopped in mouse #3, and no seizures occurred for remaining experimental period. All four Hm1a-treated animals appear healthy; they are active, groom themselves, and continue to eat and drink ad libitum, with no overt side effects observed in any Hm1a-treated animals.

Selective NaV1.1 activation rescues Dravet syndrome mice from seizures and premature death

Kay L. Richards, Carol J. Milligan, Robert J. Richardson, Nikola Jancovski, Morten Grunnet, Laura H. Jacobson, Eivind A. B. Undheim, Mehdi Mobli, Chun Yuen Chow, Volker Herzig, Agota Csoti, Gyorgy Panyi, Christopher A. Reid, Glenn F. King, and Steven Petrou

PNAS. 2018. 115:E8077-E8085 DOI: 10.1073/pnas.1804764115